Tecnotree Recognized in Gartner® Market Guide for CSP B2B Digital Marketplace Solutions

20.5.2025 08:12:00 CEST | Business Wire | Press release

Tecnotree, a global digital platform and services leader for AI-enabled 5G and cloud-native technologies, has been named a Representative Vendor in the 2025 Gartner® Market Guide for CSP B2B Digital Marketplace Solutions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250519187602/en/

The report highlights the strategic role of digital marketplaces in helping communications service providers (CSPs) diversify revenue streams, strengthen enterprise relationships, and lead ecosystem-driven innovation.

According to Gartner, “By 2028, 60% of Tier 1 CSPs will utilize digital marketplaces to serve B2B customers, a substantial increase from around 25% today.” As per our understanding, this shift reflects a growing need for CSPs to evolve beyond traditional connectivity and offer integrated, value-added solutions through agile partner ecosystems.

We believe Tecnotree’s inclusion in the report underscores its focused approach to enabling B2B and B2B2X business models through its advanced digital marketplace platform. The company has strategically invested in AI-driven technologies to enhance partner management, product discovery, and monetization for CSPs aiming to lead in the platform economy.

Tecnotree’s Marketplace Vision

Tecnotree is shaping the future of digital marketplaces with a GenAI-powered platform built for real-time, intelligent workflows. It offers automated onboarding, personalized recommendations, and scalable monetization. Built on TM Forum’s Open Digital Architecture, it supports interoperability with 59 certified Open APIs, including 9 real-world use cases.

“We think our recognition in the Gartner Market Guide validates the strong momentum behind our B2B marketplace strategy,” said Padma Ravichander, CEO of Tecnotree. “We’re delivering composable, AI-native platforms that empower CSPs to unlock new revenue, onboard partners faster, and offer differentiated services across verticals.”

AI-Native and Sector-Ready

The Tecnotree Moments platform enables CSPs to co-create sector-specific offerings across healthcare, education, OTT, gaming, and financial services. With its cloud-native, API-first design, it supports advanced models like DaaS, GenAI-powered intelligence, and dynamic pricing.

AI capabilities drive intelligent bundling, predictive partner matching, and real-time insights—helping CSPs deliver personalized experiences while managing complexity efficiently.

Key Features

Tecnotree believes that its platform aligns with Gartner report’s key marketplace capabilities:

Automated partner management
Flexible catalog and subscription billing
Self-service portals for enterprise users
AI-driven analytics and recommendations
Robust security and compliance
Open API integration for multi-vendor environments

Ecosystem-Driven Innovation

As CSPs embrace platform-based models, Tecnotree enables collaboration with ISVs, hyperscalers, fintechs, and content providers. With prebuilt integrations, flexible APIs, and co-marketing support, operators can serve both large enterprises and SMBs with speed and scale.

Gartner, Market Guide for CSP B2B Digital Marketplace Solutions, Will Rice, Khurram Shahzad, Susan Welsh de Grimaldo, 5 May 2025.

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About Tecnotree

Tecnotree is a 5G-ready digital Business Support System (BSS) player, with AI/ML capabilities and multi-cloud extensibility. Tecnotree leads the way on the TM Forum Open API Conformance with 59 certified Open APIs including 9 real-world open APIs, a testament to the company’s commitment to excellence, and continuously striving to deliver differentiated experiences and services to both CSPs and DSPs. Our agile and open-source digital BSS Stack comprises the full range (order-to-cash) of business processes and subscription management for telecom and other digital services industries creating opportunities beyond connectivity. Tecnotree also provides Fintech and B2B2X multi-experience digital marketplace to its subscriber base through the Tecnotree Moments platform to empower digitally connected communities across gaming, health, education, OTT, and other vertical ecosystems. Tecnotree is listed on the Helsinki Nasdaq (TEM1V).

View source version on businesswire.com: https://www.businesswire.com/news/home/20250519187602/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom